Gentech Crop Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.42 Cr
as on 16-11-2024
- Revenue 54.38%
(FY 2023)
- Profit 33.57%
(FY 2023)
- Ebitda 61.84%
(FY 2023)
- Net Worth 186.05%
(FY 2023)
- Total Assets 122.48%
(FY 2023)
About Gentech Crop Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹6.42 Cr.
Sanem Goud and Keerthi Sanem serve as directors at the Company.
- CIN/LLPIN
U01110TG2020PTC145424
- Company No.
145424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gentech Crop Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanem Goud  | Director | 30-Oct-2020 | Current |
| Keerthi Sanem | Director | 30-Oct-2020 | Current |
Financial Performance of Gentech Crop Sciences.
Gentech Crop Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.38% increase. The company also saw a substantial improvement in profitability, with a 33.57% increase in profit. The company's net worth Soared by an impressive increase of 186.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gentech Crop Sciences?
Unlock access to Gentech Crop Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gentech Agro Solutions Private LimitedActive 4 years 1 monthSanem Goud and Keerthi Sanem are mutual person
- Cropxpert Innovations Private LimitedActive 1 year 6 months
Sanem Goud and Keerthi Sanem are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jun 2023 | ₹1.11 M | Open |
Hdfc Bank Limited Creation Date: 09 Jun 2023 | ₹1.05 M | Open |
Hdfc Bank Limited Creation Date: 22 Dec 2022 | ₹1.21 M | Open |
How Many Employees Work at Gentech Crop Sciences?
Gentech Crop Sciences has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gentech Crop Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gentech Crop Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
